Overview
Work history
Education
Skills
Languages
Publication
References
Timeline
Generic
Hind Ibrahim Aboheimed

Hind Ibrahim Aboheimed

Riyadh,Saudi Arabia

Overview

6
6
years of professional experience

Work history

Oncology clinical pharmacist

King Khalid University Hospital
Riyadh
2023.12 - 2025.08
  • Collaborated with oncologists to develop and implement treatment plans for patients with various types of cancer.
  • Provided clinical monitoring and support for chemotherapy patients to ensure safe and effective medication usage.
  • Managed an interdisciplinary team to optimize patient care and medication therapy.

Formulary& Pharmacoeconomic Unit Member

King Khalid University Hospital
Riyadh
2023.12 - 2025.08
  • Manage and update the hospital's formulary, reviewing medications for clinical efficacy, safety, and cost‑effectiveness.
  • Lead or support the P&T Committee in evaluating new drugs, therapeutic classes, and safety alerts for potential inclusion/exclusion.
  • Develop and maintain related policies, guidelines, and standard operating procedures (SOPs), including for non‑formulary requests, off‑label use, and drug shortages.

Clinical practice guideline departmental committee

King Khalid University Hospital
Riyadh
2025.01 - Current
  • Collaborated with guideline developer and committee members to create clear, evidence-based explanations for recommendations.
  • Engaged in meetings, utilising pharmacotherapy experience and clinical judgement to guide discussions and decision-making.

Cancer and Plasma Therapeutic Subcommittee

King Khalid University Hospital
Riyadh
2025.01 - Current
  • Conducted medication evaluations to assess appropriateness of hematology and oncology drugs.
  • Reviewed all requests for drug use related to hematology and oncology.
  • Established and reviewed policies, procedures, formulary guidelines, and clinical pathways for hematology and oncology drugs.

Oncology Clinical Pharmacy Resident

National Guard Hospital
Riyadh
2019.10 - 2023.02

Education

Saudi Board‑Certified Oncology Pharmacist -

Saudi Commission for Health Specialties (SCFHS)
2023.01 -

American Board Certified Oncology Specialist -

Board of Pharmacy Specialty
United state
2023.01 -

Board Certified Pharmacotherapy Specialist -

Board of Pharmacy Specialties
United state
2022.01 -

Doctor of Pharmacy - Pharmacy

King Saud University
Riyadh, Riyadh Region
2011.01 - 2017.01

Skills

  • Interdisciplinary collaboration
  • Critical thinking and research
  • Pharmaceutical expertise
  • Effective communication
  • Leadership
  • Patient advocacy
  • Time Management

Languages

Arabic
Native
English
Advanced

Publication

  • October 2023: Aboheimed,H. Alshehri,B. The effectiveness of Netupitant/palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults undergoing hematopoietic stem cell transplantation.
    • October 2022: Appropriateness of IV Cyclosporin Dosing in pediatric patients following allogeneic hematopoietic stem cell transplantation, Presented at the 2021 American College of Clinical Pharmacy (ACCP) Virtual Poster Symposium
    • November 2020: Aloudah, N., Alhumsi, A., Alobeid, N., & Aboheimed,H. (2020). Factors impeding the supply of overthe- counter medications according to evidence-based practice: A mixed-methods study. PLOS ONE, 15(11), e0240913.
    DOI:10.1371/journal.pone.0240913
    • August 2020: Alfurayh, I., Aboheimed, H., & Carvalhal, A. (2020). Mania with Psychosis Induced by Low-Dose Trazodone. Psychiatric Annals,50(6), 264-267. DOI: 10.3928/00485713-20191104-01

References

References available upon request.

Timeline

Clinical practice guideline departmental committee

King Khalid University Hospital
2025.01 - Current

Cancer and Plasma Therapeutic Subcommittee

King Khalid University Hospital
2025.01 - Current

Oncology clinical pharmacist

King Khalid University Hospital
2023.12 - 2025.08

Formulary& Pharmacoeconomic Unit Member

King Khalid University Hospital
2023.12 - 2025.08

Saudi Board‑Certified Oncology Pharmacist -

Saudi Commission for Health Specialties (SCFHS)
2023.01 -

American Board Certified Oncology Specialist -

Board of Pharmacy Specialty
2023.01 -

Board Certified Pharmacotherapy Specialist -

Board of Pharmacy Specialties
2022.01 -

Oncology Clinical Pharmacy Resident

National Guard Hospital
2019.10 - 2023.02

Doctor of Pharmacy - Pharmacy

King Saud University
2011.01 - 2017.01
Hind Ibrahim Aboheimed